Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mylan Pharmaceuticals Inc

Clinical trials sponsored by Mylan Pharmaceuticals Inc, explained in plain language.

Now part of Viatris Inc. VTRS NASDAQ

A pharmaceutical company focused on generics and specialty medicines, now part of Viatris.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New birth control patch could offer hormonal option without estrogen

Disease control Ongoing

This phase 3 study is testing a new contraceptive patch (MR-130A-01) that delivers a progestin-only hormone through the skin. About 1630 healthy women of childbearing potential will use the patch for 13 cycles to see how well it prevents pregnancy and how safe it is. The study is…

Phase: PHASE3 • Sponsor: Mylan Pharmaceuticals Inc • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC